Literature DB >> 13861143

Cyclophosphamide in treatment of disseminated malignant disease.

C J ANDERS, N H KEMP.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS/therapy

Mesh：

Substances：

Year:  1961        PMID： 13861143      PMCID： PMC1970636          DOI： 10.1136/bmj.2.5266.1516

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  6 in total

1.  [On the value and risks of postoperative chemotherapy of malignant tumors].

Authors:  W DENK; K KARRER; P WURNIG
Journal:  Arzneimittelforschung       Date:  1961-03

2.  [Preliminary experiences with cyclophosphamide in the treatment of advanced carcinoma].

Authors:  B MOLIN
Journal:  Arzneimittelforschung       Date:  1961-03

3.  Cyclophosphamide in Hodgkin's disease and related disorders.

Authors:  J Q MATTHIAS; J J MISIEWICZ; R B SCOTT
Journal:  Br Med J       Date:  1960-12-24

4.  [First experience in treating malignant tumors with a new nitrogen mustard-phosphamidester].

Authors:  R GROSS; K LAMBERS
Journal:  Dtsch Med Wochenschr       Date:  1958-03-21       Impact factor: 0.628

5.  Cyclophosphamide in Advanced Breast Cancer.

Authors:  B A Stoll; J H Matar
Journal:  Br Med J       Date:  1961-07-29

6.  Synthetic oestrogens in mammary cancer.

Authors:  A L WALPOLE; E PATERSON
Journal:  Lancet       Date:  1949-10-29       Impact factor: 79.321
  6 in total
  8 in total

1.  High-dose mustine therapy for bronchial carcinoma.

Authors:  K P GOLDMAN
Journal:  Br Med J       Date:  1963-02-02

Review 2.  Antineoplastic and immunosuppressive drugs. 3. Adverse effects and therapeutic problems.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

3.  Cyclophosphamide in the management of advanced bronchial carcinoma.

Authors:  R D McLean
Journal:  Thorax       Date:  1965-11       Impact factor: 9.139

4.  [Life prognosis of treated and non-treated patients with plasmacytoma].

Authors:  C Ramsbott; H Gerhartz; P Obrecht
Journal:  Blut       Date:  1967-01

5.  The Clinical Application of Bone Marrow Grafting.

Authors:  D E Pegg; J G Humble; K A Newton
Journal:  Br J Cancer       Date:  1962-09       Impact factor: 7.640

6.  Prevention of acute deaths in mice after very high dose cyclophosphamide by divided dose schedule.

Authors:  B D Evans; I E Smith; R D Clutterbuck; J L Millar
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

7.  Evaluation of cyclophosphamide dosage schedules in breast cancer.

Authors:  B A Stoll
Journal:  Br J Cancer       Date:  1970-09       Impact factor: 7.640

8.  Role for the epidermal growth factor receptor in chemotherapy-induced alopecia.

Authors:  Kyle J Bichsel; Navdeep Gogia; Timothy Malouff; Zachary Pena; Eric Forney; Brianna Hammiller; Patrice Watson; Laura A Hansen
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.